[Follow-up of malignant metastatic pheochromocytoma. Discussion of the therapeutic strategy].
Fett
W
W
Hämatologische Praxis, Wuppertal, St.-Johannes-Hospital Duisburg.
Westerhausen
M
M
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004837:Epinephrine / Q000652:urine; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010673:Pheochromocytoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*
D009638:Norepinephrine; D004837:Epinephrine
Verlaufsbeobachtung bei malignem metastasiertem Phäochromozytom. Diskussion der therapeutischen Strategie.